1:
Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence.
Washington CH, Radday J, Streit TG, Boyd HA, Beach MJ, Addiss DG, Lovince R, Lovegrove MC, Lafontant JG, Lammie PJ, Hightower AW.
Filaria J. 2004 May 5;3(1):3.
PMID: 15128461 [PubMed - as supplied by publisher]
Related Articles Free article in PMC
7:
The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.
de Rochars MB, Kanjilal S, Direny AN, Radday J, Lafontant JG, Mathieu E, Rheingans RD, Haddix AC, Streit TG, Beach MJ, Addiss DG, Lammie PJ.
Am J Trop Med Hyg. 2005 Nov;73(5):888-94.
PMID: 16282299 [PubMed - indexed for MEDLINE]
Related Articles
12:
Endpoints for lymphatic filariasis programs.
Grady CA, de Rochars MB, Direny AN, Orelus JN, Wendt J, Radday J, Mathieu E, Roberts JM, Streit TG, Addiss DG, Lammie PJ.
Emerg Infect Dis. 2007 Apr;13(4):608-10.
PMID: 17553278 [PubMed - indexed for MEDLINE]
Related Articles